Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$653M |
| 2 |
Amazon
AMZN
|
+$602M |
| 3 |
ExxonMobil
XOM
|
+$473M |
| 4 |
Tesla
TSLA
|
+$437M |
| 5 |
Starbucks
SBUX
|
+$380M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Berkshire Hathaway Class A
BRK.A
|
+$511M |
| 2 |
Netflix
NFLX
|
+$427M |
| 3 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$397M |
| 4 |
Nike
NKE
|
+$373M |
| 5 |
Microsoft
MSFT
|
+$365M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.68% |
| 2 | Healthcare | 17.69% |
| 3 | Consumer Discretionary | 13.09% |
| 4 | Industrials | 7.96% |
| 5 | Consumer Staples | 7.92% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1601
SmartFinancial
SMBK
$910M
| $3.4M | 0.01% |
138,674
-200
| -0.1% | -$4.43K |
|
|
ACLX
1602
DELISTED
Arcellx
ACLX
| $3.39M | 0.01% |
61,100
+7,300
| +14% | +$329K |
|
1603
Comp X International
CIX
$358M
| $3.39M | 0.01% |
134,144
-1,454
| -1% | -$30.1K |
|
1604
ARKO Corp
ARKO
$840M
| $3.38M | 0.01% |
410,300
-472
| -0.1% | -$3.61K |
|
1605
Vera Bradley
VRA
$99M
| $3.38M | 0.01% |
438,840
+11,500
| +3% | +$83.7K |
|
1606
Dolby
DLB
$5.73B
| $3.38M | 0.01% |
39,200
-26,700
| -41% | -$2.25M |
|
1607
Vanguard International High Dividend Yield ETF
VYMI
$20.7B
| $3.38M | 0.01% |
+50,789
| New | +$3.19M |
|
1608
Dycom Industries
DY
$12.5B
| $3.37M | 0.01% |
29,300
-25,600
| -47% | -$2.43M |
|
|
ORC
1609
Orchid Island Capital
ORC
$1.27B
| $3.37M | 0.01% |
399,960
-223,400
| -36% | -$1.67M |
|
1610
AtriCure
ATRC
$1.98B
| $3.37M | 0.01% |
94,300
-47,100
| -33% | -$1.75M |
|
|
ASRT
1611
DELISTED
Assertio
ASRT
| $3.36M | 0.01% |
209,501
+39,060
| +23% | +$966K |
|
1612
iShares Core MSCI Europe ETF
IEUR
$9.09B
| $3.36M | 0.01% |
+61,000
| New | +$3.12M |
|
1613
Brown-Forman Class A
BF.A
$13.2B
| $3.35M | 0.01% |
56,276
-14,400
| -20% | -$847K |
|
|
VRE
1614
DELISTED
Veris Residential
VRE
| $3.35M | 0.01% |
213,112
-314,657
| -60% | -$4.68M |
|
|
PTVE
1615
DELISTED
Pactiv Evergreen Inc. Common stock
PTVE
| $3.35M | 0.01% |
244,200
+51,500
| +27% | +$542K |
|
|
TIXT
1616
DELISTED
TELUS International
TIXT
| $3.33M | 0.01% |
388,400
+3,895
| +1% | +$28.3K |
|
1617
Pediatrix Medical
MD
$2.03B
| $3.32M | 0.01% |
357,300
+309,100
| +641% | +$3.2M |
|
|
PLYM
1618
DELISTED
Plymouth Industrial REIT
PLYM
| $3.32M | 0.01% |
137,812
+16,200
| +13% | +$352K |
|
1619
Teleflex
TFX
$6.2B
| $3.32M | 0.01% |
13,300
-50,600
| -79% | -$10.8M |
|
|
BRY
1620
DELISTED
Berry Corp
BRY
| $3.31M | 0.01% |
471,400
+287,700
| +157% | +$2.16M |
|
1621
First Bancorp
FNLC
$402M
| $3.31M | 0.01% |
117,163
-800
| -0.7% | -$19.9K |
|
1622
Taboola.com
TBLA
$1.45B
| $3.31M | 0.01% |
763,510
+455,110
| +148% | +$1.72M |
|
1623
Haemonetics
HAE
$3.88B
| $3.29M | 0.01% |
38,500
-103,800
| -73% | -$8.97M |
|
1624
Magnachip Semiconductor
MX
$134M
| $3.28M | 0.01% |
437,688
+350,900
| +404% | +$2.56M |
|
1625
Excelerate Energy
EE
$1.25B
| $3.28M | 0.01% |
212,264
+68,764
| +48% | +$1.11M |
|
Similar funds
Renaissance Technologies's Q4 2023 Portfolio in Review
As of Q4 2023, Renaissance Technologies held 4,318 positions worth $64.6B, up 10% from $58.7B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Renaissance Technologies's Q4 2023 filing shows 702 new, 1,590 increased, 1,355 reduced and 633 closed positions. Its largest new stake was Amazon: 4,296,466 shares worth $653M. The largest sale was Berkshire Hathaway Class A, an estimated $511M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Renaissance Technologies's largest Q4 2023 buy was Amazon: 4,296,466 shares worth $653M.
- Renaissance Technologies added most to Meta Platforms (Facebook) in Q4 2023, an estimated $653M increase.
- Renaissance Technologies's biggest Q4 2023 reduction was Berkshire Hathaway Class A, cutting an estimated $511M.
- Renaissance Technologies fully exited Horizon Therapeutics Public Limited Company Ordinary Shares in Q4 2023, selling an estimated $397M.
- Renaissance Technologies's ten largest holdings make up 12% of its $64.6B portfolio in Q4 2023.
- Renaissance Technologies opened 702 new positions and closed 633 in Q4 2023.
- Renaissance Technologies's portfolio value rose 10% quarter-over-quarter to $64.6B.
Based on Renaissance Technologies's 13F filing for Q4 2023, filed 13 Feb 2024.